Henrieta Grešlíková

Author

Henrieta Grešlíková

Masaryk University

Also Known As

H Greslikova, H Grešliková, H. Greslikova, Henrieta Greslikova, Henrieta Grešlíková, Henrieta Grešlíková

Publications

522

Citations

H-Index

Concepts

All Affiliations

Masaryk University University Hospital Brno University of Ostrava University Hospital Ostrava

About

Henrieta Grešlíková is an author at Masaryk University specializing in cancer research, medicine, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	191
2	Health Sciences	3	3	68
3	Cell Biology	2	2	30
4	Engineering	1	1	112
5	Immunology	1	1	112

Henrieta Grešlíková

Publications

515

Citations

H-Index

Page 1

	Year	Citations
Soft-tissue extramedullary multiple myeloma prognosis is significantly worse in comparison to bone-related extramedullary relapse Luděk Pour, Henrieta Grešlíková, Renata Kupská, Haematologica	2013	179
Circulating serum microRNAs as novel diagnostic and prognostic biomarkers for multiple myeloma and monoclonal gammopathy of undetermined significance Lena Kubiczkova, Fedor Kryukov, Ondřej Slabý, Haematologica EngineeringImmunologyPathologyInvasive BiomarkersHematological Malignancy	2013	112
Gain of 1q21 Is an Unfavorable Genetic Prognostic Factor for Multiple Myeloma Patients Treated with High-Dose Chemotherapy Pavel Němec, Zuzana Zemanová, Henrieta Grešlíková, Biology of Blood and Marrow Transplantation	2009	70
Cytogenetics in multiple myeloma patients progressing into extramedullary disease Lenka Bešše, Lenka Sedlaříková, Henrieta Grešlíková, European Journal Of Haematology	2015	55
Genome-Wide Screening of Cytogenetic Abnormalities in Multiple Myeloma Patients Using Array-CGH Technique: A Czech Multicenter Experience Jan Smetana, Jan Fröhlich, Romana Zaoralová, BioMed Research International CytogeneticsMixed-phenotype Acute LeukemiaGeneticsPathologyGenomics	2014	25
Gain(1)(q21) is an Unfavorable Genetic Prognostic Factor for Patients With Relapsed Multiple Myeloma Treated With Thalidomide but Not for Those Treated With Bortezomib Jan Smetana, Kristina Beránková, Romana Zaoralová, Clinical Lymphoma Myeloma & Leukemia Hematological MalignancyMedicineHematologyMyeloid NeoplasiaPathology	2013	24
Nestin expression throughout multistep pathogenesis of multiple myeloma Hana Šváchová, Fedor Kryukov, Elena Kryukova, British Journal of Haematology	2013	20
Negative prognostic significance of two or more cytogenetic abnormalities in multiple myeloma patients treated with autologous stem cell transplantation Henrieta Grešlíková, Romana Zaoralová, Hana Filková, Neoplasma CytogeneticsMixed-phenotype Acute LeukemiaPathologyGenetic AberrationsMyeloid Neoplasia	2010	19
Centrosome amplification as a possible marker of mitotic disruptions and cellular carcinogenesis in multiple myeloma Elena Dementyeva, Pavel Němec, Fedor Kryukov, Leukemia Research Hematological MalignancyChromatinTumor BiologyCell DivisionMedicine	2010	11

Page 1